Essential role for signal transducer and activator of transcription-1 in pancreatic β-cell death and autoimmune type 1 diabetes of nonobese diabetic mice

Diabetes

Volumn 56, Issue 10, 2007, Pages 2561-2568

  Kim, Sunshin ^a   Hun, Sik Kim ^a   Kun, Wook Chung ^a   Seung, Hoon Oh ^a   Jong, Won Yun ^b   Im, Sin Hyeog ^c   Lee, Moon Kyu ^a   Kim, Kwang Won ^a   Lee, Myung Shik ^a,d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Daegu University   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; JANUS KINASE INHIBITOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; IMMUNOREGULATION; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE TRANSFER; MALE; MOUSE; NEWBORN; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL;

ANIMALS; APOPTOSIS; DIABETES MELLITUS, TYPE 1; ENZYME INHIBITORS; INSULIN-SECRETING CELLS; JANUS KINASES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; STAT1 TRANSCRIPTION FACTOR;

EID: 34948893439     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1372     Document Type: Article

References (50)

1. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U S A 88:527-531, 1991
2. Katz JD, Benoist C, Mathis D: T helper cell subset in insulin-dependent diabetes. Science 268:1185-1188, 1995
3. Kurrer MO, Pakala SV, Hanson HL, et al.: β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-218, 1997
4. Kim YH, Kim S, Kim KA, et al.: Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455-465, 1999
5. Kagi D, Vignaux F, Ledermann B, et al.: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530, 1994
6. Hahn S, Gehri R, Erb P: Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 146:57-79, 1995
7. Kagi D, Odermatt B, Seiler P, et al.: Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 186:989-997, 1997
8. Chervonsky AV, Wang Y, Wong FS, et al.: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
9. Allison J, Strasser A: Mechanisms of β cell death in diabetes: a minor role for CD95. Proc Natl Acad Sci U S A 95:13818-13822, 1998
10. Kim S, Kim KA, Hwang DY, et al.: Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164:2931-2936, 2000
11. Pukel C, Baquerizo H, Rabinovitch A: Destruction of rat islet cell monolayers by cytokines: synergistic interaction of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37:133-136, 1988
12. Corbett JA, McDaniel ML: Does nitric oxide mediate autoimmune destruction of β-cells? Diabetes 41:897-903, 1992
13. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
14. Thomas HE, Irawaty W, Darwiche R, et al.: IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53:113-121, 2004
15. Schott WH, Haskell BD, Tse HM, et al.: Caspase-1 is not required for type 1 diabetes in the NOD mice. Diabetes 53:99-104, 2004
16. Campbell IL, Iscaro A, Harrison LC: IFN-gamma and tumor necrosis factor-alpha: cytotoxicity to murine islets of Langerhans. J Immunol 141:2325-2329, 1988
17. Suk K, Kim S, Kim Y-H, et al.: IFNγ/TNFα synergism as the final effector in autoimmune diabetes: a key role for STAT1/IRF-1 in pancreatic β-cell death. J Immunol 166:4481-4489, 2001
18. Chen G, Hohmeier HE, Newgard CB: Expression of the transcriptional factor STAT-1 alpha in insulinoma cells protects against cytotoxic effects of multiple cytokines. J Biol Chem 276:766-772, 2001
19. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J Exp Med 199:25-34, 2004
20. Bettelli E, Sullivan B, Szabo SJ, et al.: Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 200:79-87, 2004
21. Mora C, Wong FS, Chang C-H, et al.: Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J Immunol 162:4576-4588, 1999
22. Chang I, Cho N, Kim S, et al.: Role of calcium in pancreatic islet cell death by IFNγ/TNFα. J Immunol 172:7008-7014, 2004
23. Kim HS, Kim S, Lee M-S: IFN-γ sensitizes MIN6N8 cells insulinoma cells to TNF-α-induced apoptosis by inhibiting NF-κB-mediated XIAP upregulation. Biochem Biophys Res Com 336:847-853, 2005
24. Andre-Schmutz I, Hindelang C, Benoist C, et al.: Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 29:245-255, 1999
25. Chang I, Cho N, Koh JY, et al.: Pyruvate Inhibits zinc-mediated pancreatic islet cell death and diabetes. Diabetologia 46:1220-1227, 2003
26. Turley S, Poirot L, Hattori M, et al.: Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 198:1527-1537, 2003
27. Avni O, Lee D, Macian F, et al.: Th cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3:643-651, 2002
28. Deveraux QL, Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13:239-252, 1999
29. Lakhani SA, Masud A, Kuida K, et al.: Caspase 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311:847-851, 2006
30. Chang I, Kim S, Kim JY, et al.: NF-κB protects pancreatic β-cells from TNFα-mediated apoptosis. Diabetes 52:1169-1175, 2003
31. Kim S, Millet I, Kim HS, et al.: NF-κB prevents β-cell death and autoimmune diabetes of NOD mice. Proc Natl Acad Sci U S A 104:1913-1918, 2007
32. Scarim AL, Arnush M, Blair LA, et al.: Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol 159:273-283, 2001
33. Wang F, Ma Y, Barrett JW, et al.: Disruption of Erk-dependent type 1 interferon induction breaks the myxoma virus species barrier. Nat Immunol 5:1266-1274, 2004
34. Tamada Y, Nakao K, Nagayama Y, et al.: p48 overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells. J Hepatol 37:493-499, 2002
35. Oyadomari S, Takeda K, Takiguchi M, et al.: Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A 98:10845-10850, 2001
36. Ueda H, Howson JM, Esposito L, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511, 2003
37. Cantor J, Haskins K: Effector function of diabetogenic CD4 Th1 T cell clones: a central role of TNF-α. J Immunol 175:7785-7745, 2005
38. Mueller R, Krahl T, Sarvetnick N: Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 184:1093-1099, 1996
39. Jaeschke A, Rincon M, Doran B, et al.: Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type 1 diabetes. Proc Natl Acad Sci U S A 102:6931-6935, 2005
40. Lighvani AA, Frucht DM, Jankovic D, et al.: T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 98:15137-15142, 2001
41. Takeda A, Hamano S, Yamanaka A, et al.: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170:4886-4890, 2003
42. Wang LH, Kirken RA, Erwin RA, et al.: JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J Immunol 162:3897-3904, 1999
43. Gysemans CA, Ladriere L, Callewaert H, et al: Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β-cells. Diabetes 54:2396-2403, 2005
44. Flodstrom-Tullberg M, Yadav D, Hagerkvist R, et al.: Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes 52:2696-2700, 2003
45. Chong MMW, Thoma HE, Kay TWH: Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β-cells to tumor necrosis factor. J Biol Chem 277:27945-27952, 2002
46. Hamilton-Williams EE, Palmer SE, Charton B, et al.: Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci U S A 100:6688-6693, 2003
47. Kim HS, Lee MS: Essential role of STAT1 in caspase-independent cell death of activated macrophages through p38 MAPK/STAT1/ROS pathway. Mol Cell Biol 25:6821-6833, 2005
48. + T-cells in T-cell receptor transgenic NOD mice. Diabetes 48:34-42, 1999
49. Hisahara S, Yuan J, Momo T, et al.: Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193:111-122, 2001
50. Meydan N, Grunberger T, Dadi H, et al.: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645-648, 1996